[Form 4] ChargePoint Holdings, Inc. Insider Trading Activity
ChargePoint Holdings, Inc. (CHPT) – Form 4 insider transaction
Director Jeffrey Harris reported the grant of 254,785 Restricted Stock Units (RSUs) on 07/08/2025. The RSUs carry a cost basis of $0 and convert 1-for-1 into common shares once a service-based vesting condition is met—either on the one-year anniversary of the grant or at the next annual shareholder meeting, whichever comes first.
Following the award, Harris is shown as the beneficial owner of 427,517 CHPT shares. Footnote (2) states that these shares are held for the benefit of Q-GRG VII (CP) Investment Partners, LLC, and Harris disclaims beneficial ownership.
No dispositions, sales, options, or derivative transactions were reported. The filing therefore reflects a routine equity incentive intended to align a board member’s interests with those of shareholders, with a modest dilutive impact relative to ChargePoint’s total shares outstanding.
- Director equity alignment: 254,785 RSUs link board member compensation to shareholder value.
- Transparent disclosure: Footnotes clearly identify third-party beneficiary (Q-GRG) and disclaim beneficial ownership, supporting governance best practices.
- Minor dilution: Issuance of new shares, albeit less than 0.1% of float, incrementally expands share count.
Insights
TL;DR: Routine RSU grant to director; negligible financial impact.
The Form 4 shows an at-cost award rather than an open-market purchase or sale, so it does not signal insider valuation views. 254.8 k shares represent less than 0.1% of CHPT’s ~363 m shares outstanding, implying immaterial dilution. Vesting tied to service encourages board continuity but has no immediate cash-flow or P&L implications. Overall, the filing is governance-related, not a catalyst for valuation changes.
TL;DR: Grant strengthens alignment; standard practice.
Granting RSUs that vest at the next AGM is a common method to ensure directors maintain long-term focus. Disclosure that shares are held for Q-GRG and disclaimed by Harris is transparent and compliant with Section 16 rules. No red flags emerge—no accelerated vesting, no sales, and proper attorney-in-fact signature. Impact on governance quality is neutral-to-slightly positive, but not material for investors.